{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:57:38Z","timestamp":1759229858935},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1002\/jps.20356","type":"journal-article","created":{"date-parts":[[2005,5,26]],"date-time":"2005-05-26T22:48:04Z","timestamp":1117147684000},"page":"1418-1426","source":"Crossref","is-referenced-by-count":10,"title":["Effect of device inhalational resistance on the three-dimensional configuration of the upper airway"],"prefix":"10.1016","volume":"94","author":[{"given":"Touraj","family":"Ehtezazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Horsfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Goodenough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"O'Callaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.20356_bb0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-5173(96)04526-7","article-title":"Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers. 2. Effect of peak flow rate (PIFR) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers","volume":"138","author":"deBoer","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20356_bb0015","series-title":"An introduction: The mechanics of inhaled pharmaceutical aerosol","author":"Finlay","year":"2001"},{"key":"10.1002\/jps.20356_bb0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0378-5173(01)00969-3","article-title":"Effect of an external resistance to airflow on the inspiratory flow curve","volume":"234","author":"de Koning","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20356_bb0025","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/0021-8502(96)00046-8","article-title":"Aerodynamics and aerosol particle deaggregation phenomena in model oral-pharyngeal cavities","volume":"27","author":"Li","year":"1996","journal-title":"J Aerosol Med"},{"key":"10.1002\/jps.20356_bb0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0169-409X(97)00509-7","article-title":"Aerosol particle transport and deaggregation phenomena in the mouth and throat","volume":"26","author":"Li","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.20356_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/089426801316970321","article-title":"In vitro monodisperse aerosol deposition in a mouth and throat with six different inhalation devices","volume":"14","author":"DeHaan","year":"2001","journal-title":"J Aerosol Med"},{"key":"10.1002\/jps.20356_bb0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/jam.2004.17.325","article-title":"Dynamic change of the upper airway during inhalation via aerosol delivery devices","volume":"17","author":"Ehtezazi","year":"2004","journal-title":"J Aerosol Med"},{"key":"10.1002\/jps.20356_bb0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/089426803772455668","article-title":"Studies of the human oropharyngeal airspaces using magnetic resonance imaging. I. Validation of a three-dimensional MRI method for producing ex vivo virtual and physical casts of the oropharyngeal airways during inspiration","volume":"16","author":"McRobbie","year":"2003","journal-title":"J Aerosol Med"},{"key":"10.1002\/jps.20356_bb0050","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1067\/mai.2001.119153","article-title":"The ability of the community pharmacist to learn the proper actuation techniques of inhaler devices","volume":"108","author":"Cain","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1002\/jps.20356_bb0055","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1164\/ajrccm.152.5.7582313","article-title":"Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Significance of the lateral pharyngeal walls","volume":"152","author":"Schwab","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/jps.20356_bb0060","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1164\/ajrccm.154.4.8887615","article-title":"Upper airway and soft tissue structural changes induced by CPAP in normal subjects","volume":"154","author":"Schwab","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/jps.20356_bb0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00004728-199503000-00022","article-title":"A registration and interpolation procedure for subvoxel matching of serially acquired MR images","volume":"19","author":"Hajnal","year":"1995","journal-title":"J Comput Assist Tomogr"},{"key":"10.1002\/jps.20356_bb0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0378-5173(95)04326-8","article-title":"Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers. 1. Inhalation characteristics, work of breathing and volunteers' preference in dependence of the inhaler resistance","volume":"130","author":"deBoer","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20356_bb0075","first-page":"2117","volume":"III","author":"British Pharmacopoeia","year":"2004"},{"key":"10.1002\/jps.20356_bb0080","series-title":"Preparations for inhalation","first-page":"552","year":"2002"},{"key":"10.1002\/jps.20356_bb0085","series-title":"Aerosols, metered dose inhalers, and dry powder inhalers","first-page":"2253","author":"USP 27 NF22","year":"2004"},{"key":"10.1002\/jps.20356_bb0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2125.2002.01554.x","article-title":"The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide","volume":"53","author":"Penson","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1002\/jps.20356_bb0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/rr58","article-title":"The lung as a route for systemic delivery of therapeutic proteins and peptides","volume":"2","author":"Agu","year":"2001","journal-title":"Respir Res"},{"key":"10.1002\/jps.20356_bb0100","first-page":"2316","article-title":"Aerosol granulocyte macrophage-colony stimulating factor: A low toxicity, lung-specific biological therapy in patients with lung metastases","volume":"5","author":"Anderson","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1002\/jps.20356_bb0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0378-5173(99)00341-5","article-title":"Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and a dry powder inhaler, Turbuhaler","volume":"193","author":"Borgstrom","year":"2000","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20356_bb0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1164\/ajrccm.152.1.7599841","article-title":"Added external resistance reduces oropharyngeal deposition and increases lung deposition of aerosol particles in asthmatics","volume":"152","author":"Svartengren","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/jps.20356_bb0115","first-page":"1556","article-title":"Oropharyngeal deposition of 3.5 microns particles inhaled through an elongated mouthpiece","volume":"9","author":"Svartengren","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1002\/jps.20356_bb0120","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0091-6749(99)70417-3","article-title":"Is the correct use of a dry powder inhaler (Turbohaler) age dependent?","volume":"103","author":"De Boeck","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1002\/jps.20356_bb0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-5173(93)90125-Y","article-title":"Total and regional lung deposition of terbutaline sulphate inhaled via a pressurised MDI or via Turbuhaler","volume":"97","author":"Borgstrom","year":"1993","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.20356_bb0130","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/rmed.2001.1107","article-title":"A comparison of the lung deposition of budesonide from Easyhaler, Turbuhaler and pMDI plus spacer in asthmatic patients","volume":"95","author":"Hirst","year":"2001","journal-title":"Respir Med"},{"key":"10.1002\/jps.20356_bb0135","first-page":"3","article-title":"In vivo evaluation of the new multiple dose powder inhaler and the Rotahaler using the gamma scintigraphy","volume":"2","author":"Vidgren","year":"1990","journal-title":"Acta Pharm Nord"},{"key":"10.1002\/jps.20356_bb0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/rmed.2001.1276","article-title":"Evolution of dry powder inhaler design, formulation, and performance","volume":"96","author":"Newman","year":"2002","journal-title":"Respir Med"},{"key":"10.1002\/jps.20356_bb0145","series-title":"Respiratory drug delivery V","first-page":"273","article-title":"Effect of inlet throat on the correlation between measured fine particle dose and lung deposition","author":"Olsson","year":"1996"},{"key":"10.1002\/jps.20356_bb0150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0168-3659(00)00362-X","article-title":"Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance","volume":"70","author":"Bosquillon","year":"2001","journal-title":"J Control Release"},{"key":"10.1002\/jps.20356_bb0155","series-title":"Fluid mechanics and particle deposition in the oropharynx: The factors that really matter. Respiratory Drug Delivery VIII","first-page":"171","author":"Finlay","year":"2002"},{"key":"10.1002\/jps.20356_bb0160","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0378-5173(03)00156-X","article-title":"The influence of carrier and drug morphology on drug delivery from dry powder formulations","volume":"257","author":"Larhrib","year":"2003","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916317968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916317968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T19:50:26Z","timestamp":1550778626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916317968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0022354916317968"],"URL":"https:\/\/doi.org\/10.1002\/jps.20356","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}